Cortisone acetate
Cortone (cortisone acetate) is a small molecule pharmaceutical. Cortisone acetate was first approved as Cortisone acetate on 1982-01-01. It is used to treat adrenal insufficiency, allergic rhinitis, ankylosing spondylitis, asthma, and atopic dermatitis amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Show 7 more
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cortisone acetate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CORTISONE ACETATE | Impax Laboratories | N-009458 DISCN | 1982-01-01 | 1 products |
| CORTONE | Merck & Co | N-007110 DISCN | 1982-01-01 | 2 products |
| CORTONE | Merck & Co | N-007750 DISCN | 1982-01-01 | 1 products, RLD |
| CORTISONE ACETATE | Panray Corporation | N-008284 DISCN | 1982-01-01 | 2 products |
| CORTISONE ACETATE | Pharmacia & Upjohn | N-008126 DISCN | 1982-01-01 | 4 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| cortisone acetate | ANDA | 2025-06-06 |
Indications
FDA
EMA
Show 19 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
H: Systemic hormonal preparations, excl. sex hormones and insulins
— H02: Corticosteroids for systemic use
— H02A: Corticosteroids for systemic use, plain
— H02AB: Glucocorticoids, systemic
— H02AB10: Cortisone
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01B: Antiinflammatory agents, ophthalmologic
— S01BA: Corticosteroid ophthalmologic antiinflammatory agents, plain
— S01BA03: Cortisone
HCPCS
Code | Description |
|---|---|
| J1700 | Injection, hydrocortisone acetate, up to 25 mg |
Clinical
Clinical Trials
1728 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 35 | 60 | 23 | 3 | 4 | 106 |
| Adrenal insufficiency | D000309 | — | — | 6 | 6 | 11 | 22 | 36 | 79 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 7 | 6 | — | 3 | 53 | 67 |
| Leukemia | D007938 | — | C95 | 21 | 34 | 15 | 2 | 4 | 65 |
| Depression | D003863 | — | F33.9 | 7 | 5 | 2 | 2 | 49 | 61 |
| Septic shock | D012772 | — | A48.3 | 1 | 12 | 18 | 11 | 18 | 55 |
| Healthy volunteers/patients | — | — | — | 12 | 4 | 1 | 8 | 24 | 48 |
| Cushing syndrome | D003480 | EFO_0003099 | E24 | 2 | 11 | 5 | 1 | 30 | 48 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | 1 | 8 | 14 | 9 | 17 | 46 |
| Psychological stress | D013315 | — | — | 2 | — | 1 | 1 | 40 | 44 |
Show 181 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | — | C61 | 8 | 36 | 10 | — | 6 | 56 |
| Burkitt lymphoma | D002051 | — | C83.7 | 7 | 25 | 9 | — | — | 37 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 13 | 19 | 2 | — | 2 | 31 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 17 | 12 | 3 | — | — | 28 |
| Physiological stress | D013312 | — | — | — | — | 1 | — | 22 | 23 |
| Precursor t-cell lymphoblastic leukemia-lymphoma | D054218 | — | — | 9 | 15 | 5 | — | — | 21 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 4 | 3 | — | 15 | 20 |
| Covid-19 | D000086382 | — | U07.1 | — | — | 7 | — | 12 | 19 |
| Neoplasms | D009369 | — | C80 | 3 | 8 | 1 | — | 6 | 16 |
| Psychological well-being | D000092862 | — | — | 1 | — | 1 | — | 14 | 16 |
Show 131 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Motor activity | D009043 | EFO_0003940 | — | — | 1 | — | — | 23 | 24 |
| Recurrence | D012008 | — | — | 12 | 13 | — | — | 3 | 19 |
| Stress fractures | D015775 | — | M84.3 | 1 | 1 | — | — | 15 | 17 |
| Adrenal gland neoplasms | D000310 | EFO_0003850 | C74 | — | 1 | — | — | 11 | 12 |
| Hematologic neoplasms | D019337 | — | — | 5 | 5 | — | — | 1 | 9 |
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | 1 | 4 | — | — | 5 | 9 |
| Adrenocortical carcinoma | D018268 | — | — | 1 | 4 | — | — | 3 | 8 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | 2 | — | — | 5 | 8 |
| Anorexia nervosa | D000856 | EFO_0004215 | F50.0 | — | 1 | — | — | 6 | 7 |
| Aging | D000375 | GO_0007568 | R41.81 | — | 1 | — | — | 5 | 6 |
Show 121 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | 8 | 9 |
| Overweight | D050177 | — | E66.3 | 1 | — | — | — | 7 | 8 |
| Caregiver burden | D000084802 | — | — | 1 | — | — | — | 5 | 6 |
| Blood pressure | D001794 | EFO_0004325 | — | 2 | — | — | — | 3 | 5 |
| Chronic pain | D059350 | — | — | 1 | — | — | — | 4 | 5 |
| Cocaine-related disorders | D019970 | — | F14 | 1 | — | — | — | 4 | 5 |
| Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 1 | — | — | — | 4 | 5 |
| Sleep deprivation | D012892 | — | F51.12 | 2 | — | — | — | 2 | 4 |
| Agnosia | D000377 | EFO_0007136 | F88 | 1 | — | — | — | 3 | 4 |
| Alcohol drinking | D000428 | EFO_0004329 | — | 1 | — | — | — | 3 | 4 |
Show 72 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dental implants | D015921 | — | — | — | — | — | — | 11 | 11 |
| Dental anxiety | D016854 | — | — | — | — | — | — | 10 | 10 |
| Psychological burnout | D000077062 | — | Z73.0 | — | — | — | — | 9 | 9 |
| Breast feeding | D001942 | — | — | — | — | — | — | 8 | 8 |
| Psychological distress | D000079225 | — | — | — | — | — | — | 8 | 8 |
| Nursing care | D009732 | — | — | — | — | — | — | 8 | 8 |
| Occupational stress | D000073397 | — | — | — | — | — | — | 7 | 7 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | — | — | 7 | 7 |
| Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 6 | 6 |
| Infertility | D007246 | EFO_0000545 | — | — | — | — | — | 5 | 5 |
Show 378 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Cortisone acetate |
| INN | cortisone |
| Description | Cortisone acetate is a corticosteroid hormone. |
| Classification | Small molecule |
| Drug class | Corticosteroid; Glucocorticoid |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C |
Identifiers
| PDB | — |
| CAS-ID | 50-04-4 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1650 |
| ChEBI ID | 3897 |
| PubChem CID | 5745 |
| DrugBank | DB01380 |
| UNII ID | 883WKN7W8X (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Cortisone acetate
+
Cortisone
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
46,079 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use